Medical Data Vision Co., Ltd. (TYO:3902)
1,684.00
0.00 (0.00%)
Inactive · Last trade price on Apr 23, 2026
Medical Data Vision Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 63,751 | 63,902 | 14,901 | 25,019 | 34,301 | 48,590 | |
Market Cap Growth | 317.87% | 328.84% | -40.44% | -27.06% | -29.41% | -56.54% |
Enterprise Value | 62,066 | 62,222 | 13,092 | 22,249 | 32,452 | 45,667 |
Last Close Price | 1684.00 | 1688.00 | 393.00 | 643.71 | 873.53 | 1203.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 227.68 | 228.22 | - | 25.56 | 39.43 | 44.70 |
Forward PE | 102.68 | 113.67 | 21.96 | 19.23 | 25.17 | 41.36 |
PS Ratio | 9.75 | 9.77 | 2.52 | 3.90 | 5.62 | 8.57 |
PB Ratio | 20.51 | 20.55 | 4.73 | 5.80 | 9.51 | 11.56 |
P/TBV Ratio | 20.95 | 21.00 | 4.91 | 6.01 | 10.53 | 12.37 |
P/FCF Ratio | 88.54 | 88.75 | - | 15.78 | 40.02 | 45.93 |
P/OCF Ratio | 81.52 | 81.72 | - | 15.48 | 37.69 | 44.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.49 | 9.52 | 2.22 | 3.47 | 5.32 | 8.05 |
EV/EBITDA Ratio | 136.41 | 135.26 | 100.71 | 11.89 | 17.02 | 26.41 |
EV/EBIT Ratio | 178.86 | 176.77 | 4364.10 | 12.56 | 18.46 | 28.65 |
EV/FCF Ratio | 86.20 | 86.42 | - | 14.03 | 37.87 | 43.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Debt / Equity Ratio | -0.55 | -0.55 | -0.43 | -0.75 | -0.63 | -0.77 |
Net Debt / EBITDA Ratio | -3.72 | -3.72 | -10.36 | -1.72 | -1.19 | -1.86 |
Net Debt / FCF Ratio | -2.38 | -2.38 | 1.31 | -2.03 | -2.64 | -3.04 |
Asset Turnover | 1.37 | 1.37 | 1.08 | 1.16 | 1.17 | 1.05 |
Inventory Turnover | 136.97 | 136.97 | 210.13 | 146.10 | 89.58 | 45.73 |
Quick Ratio | 1.82 | 1.82 | 1.62 | 2.39 | 2.68 | 3.44 |
Current Ratio | 2.22 | 2.22 | 2.16 | 2.58 | 2.92 | 3.64 |
Return on Equity (ROE) | 8.82% | 8.82% | -21.50% | 24.11% | 21.94% | 26.35% |
Return on Assets (ROA) | 4.62% | 4.62% | 0.03% | 19.91% | 21.07% | 18.36% |
Return on Invested Capital (ROIC) | 27.23% | 21.99% | 0.21% | 88.41% | 90.84% | 114.41% |
Return on Capital Employed (ROCE) | 10.80% | 10.80% | 0.10% | 40.10% | 47.60% | 37.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.44% | 0.44% | -5.31% | 3.91% | 2.54% | 2.24% |
FCF Yield | 1.13% | 1.13% | -6.92% | 6.34% | 2.50% | 2.18% |
Dividend Yield | - | - | 1.65% | 1.01% | 0.69% | 0.46% |
Payout Ratio | 87.50% | 87.50% | - | 23.29% | 24.94% | 12.97% |
Buyback Yield / Dilution | 0.79% | 0.79% | 0.10% | 0.10% | 2.44% | 0.81% |
Total Shareholder Return | 0.79% | 0.79% | 1.75% | 1.11% | 3.12% | 1.27% |